These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 8185666)

  • 1. Demonstration of a direct effect on hepatic acyl CoA: cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamster.
    Burrier RE; Deren S; McGregor DG; Hoos LM; Smith AA; Davis HR
    Biochem Pharmacol; 1994 Apr; 47(9):1545-51. PubMed ID: 8185666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.
    Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A
    Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between bioavailability and hypocholesterolemic activity of YM17E, an inhibitor of ACAT, in cholesterol-fed rats.
    Uchida T; Aoyama K; Watanabe T; Higuchi S
    Atherosclerosis; 1998 Mar; 137(1):97-106. PubMed ID: 9568741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters.
    Sugiyama Y; Ishikawa E; Odaka H; Miki N; Tawada H; Ikeda H
    Atherosclerosis; 1995 Feb; 113(1):71-8. PubMed ID: 7755657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of hepatic cholesterol ester hydrolase and acyl-coenzyme A:cholesterol acyltransferase in the rat.
    Stone BG; Evans CD; Fadden RJ; Schreiber D
    J Lipid Res; 1989 Nov; 30(11):1681-90. PubMed ID: 2614270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties.
    Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N
    Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A selective inhibitor of intestinal ACAT, EAB309 suppresses both intestinal and hepatic cholesterol output and stimulates chylomicron removal.
    Umeda Y; Hirano T; Kako Y; Kamagata K; Okuyama K; Suzuki K
    Life Sci; 1998; 63(13):PL187-95. PubMed ID: 9763214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypolipidemic action of the ACAT inhibitor HL-004 in hamsters fed normal chow.
    Murakami S; Ohta Y; Asami Y; Yamagishi I; Toda Y; Sato M; Tomisawa K
    Gen Pharmacol; 1996 Dec; 27(8):1383-6. PubMed ID: 9304411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma cholesterol reducing effect of FR129169, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in the rat.
    Sakuma Y; Hagihara H; Ohne K; Nagayoshi A; Mutoh S; Ito Y; Notsu Y; Okuhara M
    Jpn J Pharmacol; 1996 Jan; 70(1):35-41. PubMed ID: 8822087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of acyl CoA: cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestine.
    Burrier RE; Smith AA; McGregor DG; Hoos LM; Zilli DL; Davis HR
    J Pharmacol Exp Ther; 1995 Jan; 272(1):156-63. PubMed ID: 7815329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of simvastatin and cholestyramine, alone and in combination, on hepatic cholesterol metabolism in the male rat. off.
    Shand JH; West DW
    Lipids; 1995 Oct; 30(10):917-26. PubMed ID: 8538379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism by which an ACAT inhibitor (CL 277,082) influences plasma lipoproteins in the rat.
    Balasubramaniam S; Simons LA; Chang S; Roach PD; Nestel PJ
    Atherosclerosis; 1990 May; 82(1-2):1-5. PubMed ID: 2360913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of correlation between ACAT mRNA expression and cholesterol esterification in primary liver cells.
    Rea TJ; DeMattos RB; Homan R; Newton RS; Pape ME
    Biochim Biophys Acta; 1996 Jan; 1299(1):67-74. PubMed ID: 8555254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological properties of YM17E, an acyl-CoA:cholesterol acyltransferase inhibitor, and diarrheal effect in beagle dogs.
    Kashiwa M; Masuyama Y; Miyauchi H; Uchida T; Naganuma S; Kakuta H; Terada M; Kiriyama T; Matsuda K; Ito N; Iizumi Y; Takenaka T
    Jpn J Pharmacol; 1997 Jan; 73(1):41-50. PubMed ID: 9032133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
    Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
    Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
    Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
    Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary fatty acids regulate acyl-CoA:cholesterol acyltransferase and cytosolic cholesteryl ester hydrolase in hamsters.
    Lee JY; Carr TP
    J Nutr; 2004 Dec; 134(12):3239-44. PubMed ID: 15570019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.
    Krause BR; Black A; Bousley R; Essenburg A; Cornicelli J; Holmes A; Homan R; Kieft K; Sekerke C; Shaw-Hes MK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):734-43. PubMed ID: 8246149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein phosphatase 1 and 2A inhibitors activate acyl-CoA:cholesterol acyltransferase and cholesterol ester formation in isolated rat hepatocytes.
    Hernández ML; Martínez MJ; López de Heredia M; Ochoa B
    Biochim Biophys Acta; 1997 Nov; 1349(3):233-41. PubMed ID: 9434137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the acyl-CoA: cholesterol O-acyltransferase inhibitor, CL 277082, on cholesteryl ester accumulation in rabbit macrophage-rich granulomas and hepatic tissue.
    Kelley JL; Suenram CA; Rozek MM; Schaffer SA; Schwartz CJ
    Biochim Biophys Acta; 1988 May; 960(1):83-90. PubMed ID: 3358947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.